Neurology 2002;59:162-168
© 2002 American Academy of Neurology
Views & Reviews
Recessive inheritance and variable penetrance of slow-channel congenital myasthenic syndromes
R. Croxen, DPhil,
C. Hatton, PhD,
C. Shelley, BSc,
M. Brydson, BSc,
G. Chauplannaz, MD,
H. Oosterhuis, MD,
A. Vincent, FRCPath,
J. Newsom-Davis, FRS,
D. Colquhoun, FRS and
D. Beeson, PhD
From the Neurosciences Group (Drs. Croxen, Vincent, and Beeson, M. Brydson, and J. Newsom-Davis), Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Oxford; Department of Pharmacology (Dr. Hatton, C. Shelley, and D. Colquhoun), University College London, United Kingdom; Hôpital Neurologique et Universite Claude Bernard (Dr. Chauplannaz), Lyon, France; and Department of Neurology (Dr. Oosterhuis), Academic Hospital, Groningen, the Netherlands.
Address correspondence and reprint requests to Dr. David Beeson, Neurosciences Group, Weatherall Institute of Molecular Medicine, The John Radcliffe, Headington, Oxford OX3 9DS, UK; e-mail: dbeeson{at}hammer.imm.ox.ac.uk
Background: Slow-channel congenital myasthenic syndromes (SCCMS) typically show dominant inheritance. They are caused by missense mutations within the subunits of muscle nicotinic acetylcholine receptors (AChR) that result in prolonged ion channel activations. SCCMS mutations within the AChR  subunit are located in various functional domains, whereas fully described mutations in AChR non- subunits have, thus far, been located only in the M2 channel-lining domain. The authors identified and characterized two  -subunit mutations, located outside M2, that underlie SCCMS in three kinships. In two of the three kinships, the syndrome showed an atypical inheritance pattern.
Methods: These methods included clinical diagnosis, mutation detection, haplotype analysis, and functional expression studies using single-channel recordings of mutant AChR transiently transfected into HEK293 cells.
Results: The authors identified two SCCMS mutations in the AChR subunit, L78P and L221F. Both mutations prolonged ACh-induced ion channel activations. L78P is present in a consanguineous family and appears to be pathogenic only when present on both alleles, and L221F shows variable penetrance in one of the two families that were identified harboring this mutation.
Conclusion: SCCMS mutations may show a recessive inheritance pattern and variable penetrance. A diagnosis of SCCMS should not be ruled out in cases of CMS with an apparent recessive inheritance pattern.
This article has been cited by other articles:
|
|
|
|
 
S. Elenes, M. Decker, G. D. Cymes, and C. Grosman
Decremental Response to High-Frequency Trains of Acetylcholine Pulses but Unaltered Fractional Ca2+ Currents in a Panel of "Slow-Channel Syndrome" Nicotinic Receptor Mutants
J. Gen. Physiol.,
February 1, 2009;
133(2):
151 - 169.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Voluntary partial retraction of: Recessive inheritance and variable penetrance of slow-channel congenital myasthenic syndromes
Neurology,
January 20, 2009;
72(3):
294 - 294.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J.-C. Hoda, W. Gu, M. Friedli, H. A. Phillips, S. Bertrand, S. E. Antonarakis, D. Goudie, R. Roberts, I. E. Scheffer, C. Marini, et al.
Human Nocturnal Frontal Lobe Epilepsy: Pharmocogenomic Profiles of Pathogenic Nicotinic Acetylcholine Receptor {beta}-Subunit Mutations outside the Ion Channel Pore
Mol. Pharmacol.,
August 1, 2008;
74(2):
379 - 391.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. Mihaylova, J. S. Muller, J. J. Vilchez, M. A. Salih, M. M. Kabiraj, A. D'Amico, E. Bertini, J. Wolfle, F. Schreiner, G. Kurlemann, et al.
Clinical and molecular genetic findings in COLQ-mutant congenital myasthenic syndromes
Brain,
March 1, 2008;
131(3):
747 - 759.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. H. Gillingwater, T. M. Wishart, P. E. Chen, J. E. Haley, K. Robertson, S. H.-F. MacDonald, S. Middleton, K. Wawrowski, M. J. Shipston, S. Melmed, et al.
The neuroprotective WldS gene regulates expression of PTTG1 and erythroid differentiation regulator 1-like gene in mice and human cells
Hum. Mol. Genet.,
February 15, 2006;
15(4):
625 - 635.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Shelley and D. Colquhoun
A human congenital myasthenia-causing mutation ({varepsilon}L78P) of the muscle nicotinic acetylcholine receptor with unusual single channel properties
J. Physiol.,
April 15, 2005;
564(2):
377 - 396.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Webster, M. Brydson, R. Croxen, J. Newsom-Davis, A. Vincent, and D. Beeson
Mutation in the AChR ion channel gate underlies a fast channel congenital myasthenic syndrome
Neurology,
April 13, 2004;
62(7):
1090 - 1096.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Abdelgany, M. Wood, and D. Beeson
Allele-specific silencing of a pathogenic mutant acetylcholine receptor subunit by RNA interference
Hum. Mol. Genet.,
October 16, 2003;
12(20):
2637 - 2644.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. S. Muller, G. Mildner, W. Muller-Felber, U. Schara, K. Krampfl, B. Petersen, S. Petrova, R. Stucka, W. Mortier, J. Bufler, et al.
Rapsyn N88K is a frequent cause of congenital myasthenic syndromes in European patients
Neurology,
June 10, 2003;
60(11):
1805 - 1810.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C J Hatton, C Shelley, M Brydson, D Beeson, and D Colquhoun
Properties of the human muscle nicotinic receptor, and of the slow-channel myasthenic syndrome mutant {varepsilon}L221F, inferred from maximum likelihood fits
J. Physiol.,
March 15, 2003;
547(3):
729 - 760.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
